DataJoint Launches Agentic Layer for R&D
DataJoint has launched an agent-based AI control layer for scientific and R&D workflows. The platform is designed to provide a controlled execution environment for AI agents in regulated research fields. The company aims to enable more defensible and reproducible AI-driven research.
- DataJoint originated in a neuroscience lab at Baylor College of Medicine in 2009, created by founder and CTO Dimitri Yatsenko. The company, initially named Vathes LLC, was re-incorporated as DataJoint Inc. in January 2024. - The company's core offering is an open-source framework for managing scientific data pipelines, available in both Python and MATLAB. It is built on a relational data model to ensure data integrity and reproducibility in complex research workflows. - In September 2025, DataJoint announced a $4.9M seed funding round co-led by Nina Capital, Inoca Capital Partners, and Capital Factory to expand its SaaS platform into life sciences and pharmaceutical companies. - The company has significant roots in academia and is used by researchers at institutions like Johns Hopkins University, UCSF, and Harvard Medical School. It also has a history of receiving NIH grants, including a $2.1M SBIR grant in 2022 and a $3.78M grant for the "DataJoint Elements" project, which develops open-source neurophysiology data workflows. - DataJoint's platform is designed to address the challenges of managing multi-modal data in research, such as synchronizing data streams from various experimental sources like calcium imaging, electrophysiology, and pose estimation. - Prior to this new agentic layer, the company's focus was on providing a "computational database" that unifies data management with processing and analysis to create a traceable and queryable record of a research study.
